Elumeo (ELB.DE) traded flat 0 % during a 24 hours period ending at 04:14 PM Central Europe on Monday 26th. One Elumeo stock can currently be bought for about EUR 2.28 on popular exchanges. Current supply of Elumeo stocks is 5.9 mn. Elumeo has a current market capitalization of EUR 12.9 mn and approximately EUR 3.1 k worth of Elumeo was traded on exchanges in the last 24 hours. Since last month end, Elumeo has traded 1.87 % up. Simple moving average of last 200 days is at EUR 2.02. The highest price of past 52 weeks was recorded at EUR 2.6 on 01/13/2026. 52 weeks low was at EUR 1.6 on 06/12/2026.

Here is how related stocks have performed in the past 24 hours:

  • Syzygy (SYZ.DE) traded down -0.67 % and now trades at EUR 0.89. Syzygy has a market capitalisation of EUR 12 mn.

  • Schweizer Electronic (SCE.DE) traded up 7.99 % and now trades at EUR 4.05. Schweizer Electronic has a market capitalisation of EUR 14.8 mn. Current price/earnings ratio for Schweizer Electronic is 2.25.

  • Tonkens Agrar (GTK.DE) traded down -5.13 % and now trades at EUR 7.45. Tonkens Agrar has a market capitalisation of EUR 12.3 mn.

  • Tme Pharma (ALTME.PA) traded up 12.32 % and now trades at EUR 0.12. Tme Pharma has a market capitalisation of EUR 11.7 mn. TME Pharma NV has announced a restructuring of its debt, extending maturities to the end of June 2028 and securing additional bond financing. The company has extended all existing debt obligations to that date, simultaneously repaying a portion of external creditors’ principal in cash. A new, non‑dilutive bond of €250 000 has been issued by the CEO, and a further €500 000 of bonds has been sold to Hexagon Capital Fund, which also receives a sizeable block of subscription rights. These measures are intended to broaden the firm’s financial horizon to the second quarter of 2028 while limiting shareholder dilution. TME Pharma is also pursuing a licensing agreement for its lead cancer asset, NOX‑A12, to generate cash flow, and will disclose progress when negotiations conclude. The restructuring has received approval from the board and supervisory committee.

  • Geratherm Medical (GME.DE) traded up 1.82 % and now trades at EUR 2.22. Current market capitalisation for Geratherm Medical is EUR 12.1 mn.

About Elumeo

The Elumeo SE company, operating in Germany with its base in Berlin, specializes in the manufacturing and distribution of jewelry products. This consumer discretionary industry textiles apparel & luxury goods oriented business offers a diverse range of pieces featuring a variety of gemstones through several sales channels in the e-commerce and smart broadcasting sectors, serving customers globally.